- Contractors
- Leidos Biomedical Research Inc
Leidos Biomedical Research Inc
Federal contractor · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Leidos Biomedical Research has 195 federal contracts of $100,000 or more active since October 2023, with $11.9B obligated, from 1 agency. 106 are still running, 56 ending within 18 months.
- Contracts
- 195 since FY2024$11,890,214,013 obligated, contracts of $100,000 or more
- Running now
- 106 contracts35 ended in the last 12 months
- Biggest customer
- National Institutes of Health$11.9B on 195 contracts
- UEI
- HV8BH9BPG8Y9Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Contracts by start year
Show as table
| Fiscal year | Contracts |
|---|---|
| FY2020 | $2,866,299,621 |
| FY2021 | $449,255,134 |
| FY2022 | $284,061,280 |
| FY2023 | $248,844,240 |
| FY2024 | $604,691,390 |
| FY2025 | $1,154,507,165 |
| FY2026 | $129,466,579 |
Running contracts
The 100 that end soonest, of 106 running. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| FY24 Facilities to C - 126610 B555 Chiller Vfd InstallNational Institutes of Health · 75N91024F00019 | $813,345 | Nov 24, 2026within a month | MD |
| HHSN261201500003I; HHSN26100080; 400.001.0080.0001; Nci Od-Frederick; Appropriated; 125073 Bldg. 560, Roof Exhaust Stacks; 9/24/2018 - 3/18/2022National Institutes of Health · 75N91018F00080 | $9,985,093 | Dec 31, 2026in 1 month | MD |
| Wedgewood Expansion Design Suites M & NNational Institutes of Health · 75N91021F00019 | $7,763,273 | Jan 26, 2027in 2 months | MD |
| FY25 to-C Refurbish ElevatorsNational Institutes of Health · 75N91025F00008 | $10,123,627 | Jan 27, 2027in 2 months | MD |
| FY24 Facilities to J Atrf Bdp Facility ImprovementsNational Institutes of Health · 75N91024F00031 | $413,982 | Jan 27, 2027in 2 months | MD |
| On Behalf of Dcr Facilitate the Conduct of an Observational Study to Characterize Patients With Covid-19 Infection (10,000 Subjects).National Institutes of Health · 75N91020F00008 | $18,109,529 | Jan 31, 2027in 2 months | MD |
| This Is a Cpff to to Refurbish Apa Buildings 1034National Institutes of Health · 75N91022F00031 | $6,274,892 | Feb 5, 2027in 2 months | MD |
| This Is a Cpff to to Refurbish Apa Buildings (1033).National Institutes of Health · 75N91022F00030 | $6,232,704 | Feb 5, 2027in 2 months | MD |
| FY22 - Apa Buildings - Building 2National Institutes of Health · 75N91022F00028 | $6,180,966 | Feb 5, 2027in 2 months | MD |
| FY22 - Apa Buildings - Building 1National Institutes of Health · 75N91022F00027 | $5,729,256 | Feb 5, 2027in 2 months | MD |
| Nci-Dcp-21-0103 Coordinating Center for the Nci Cervical Cancer Last Mile Initiative Self-Sampling for Hpv Testing to Improve Cervical Cancer Prevention Ship TrialNational Institutes of Health · 75N91021F00014 | $7,985,184 | Feb 26, 2027in 3 months | MD |
| Niaid Covid-19 ACTIV3National Institutes of Health · 75N91020F00039 | $159,121,570 | Feb 28, 2027in 3 months | MD |
| Characterization of MpoxNational Institutes of Health · 75N91025F00017 | $5,583,900 | Mar 28, 2027in 4 months | MD |
| Data Systems Update, Data Integration, and Computational Applications to Support Drug Discovery and Therapeutics DevelopmentNational Institutes of Health · 75N91020F00015 | $8,410,146 | Mar 31, 2027in 4 months | MD |
| Imaging Support for Apollo 5, MoonshotNational Institutes of Health · 75N91019F00131 | $7,749,238 | Apr 14, 2027in 4 months | MD |
| FY232 Facilities to G-B1073 Mold RemediationNational Institutes of Health · 75N91023F00014 | $4,955,434 | Apr 27, 2027in 5 months | MD |
| FY25 to-H W3F1 RenovationsNational Institutes of Health · 75N91025F00026 | $1,856,809 | May 18, 2027in 6 months | MD |
| Development of Target Characterization Methods for Novel Cancer MarkersNational Institutes of Health · 75N91020F00026 | $56,499,671 | May 25, 2027in 6 months | MD |
| FY23 Facilities to-aNational Institutes of Health · 75N91023F00005 | $11,826,515 | Jun 24, 2027in 7 months | MD |
| Ind-Directed Development of Antiviral Therapies to Combat Diseases of Pandemic PotentialNational Institutes of Health · 75N91022F00010 | $16,869,382 | Jul 26, 2027in 8 months | MD |
| Nci Operational Task Order, FY26-FY27National Institutes of Health · 75N91025F00016 | $825,985,691 | Aug 30, 2027in 9 months | MD |
| Niaid Vrc FY26-27 Operational Task OrderNational Institutes of Health · 75N91025F00014 | $87,806,507 | Aug 30, 2027in 9 months | MD |
| Cptac Biospecimen CollectionNational Institutes of Health · 75N91020F00030 | $37,727,154 | Aug 30, 2027in 9 months | MD |
| The Niaid Dir FY26-27 Operational Task OrderNational Institutes of Health · 75N91025F00013 | $17,766,274 | Aug 30, 2027in 9 months | MD |
| Niaid / Childrens National Medical Center Joint Clinical Research Program (Jcrp) Immunologic and Infectious Diseases Clinical ResearchNational Institutes of Health · 75N91022F00021 | $10,001,104 | Sep 1, 2027in 9 months | MD |
| Hngr(310)Fc GMP3 Campaign and Octet Method DevelopmentNational Institutes of Health · 75N91019F00140 | $9,222,324 | Sep 2, 2027in 9 months | MD |
| Discovery and Development of Cancer Therapeutics for Next ProgramNational Institutes of Health · 75N91022F00019 | $22,364,766 | Sep 8, 2027in 9 months | MD |
| Niaid Dmid Influenza Vaccine Project (H5N1) - Influenza Variant Virus VaccinesNational Institutes of Health · 75N91024F00032 | $7,985,002 | Sep 8, 2027in 9 months | MD |
| Stable Clone Production for Anti-Ebv Monoclonal AntibodiesNational Institutes of Health · 75N91023F00020 | $3,237,758 | Sep 10, 2027in 9 months | MD |
| Ncats-Dpi-22-0101 - Creation of an Open-Source Process to Manufacture Aav Vector-Based Gene Therapy Candidates for Non-Commercial Clinical StudiesNational Institutes of Health · 75N91022F00016 | $13,973,744 | Sep 11, 2027in 9 months | MD |
| Virtual Research Support PilotNational Institutes of Health · 75N91022F00023 | $8,703,603 | Sep 14, 2027in 9 months | MD |
| Vrc Hiv Mab-Research, Development, and Production to Support Hiv Monoclonal Antibody Development - the Primary Objective Is to Support Cell Line Development, Process Development, Analytical…National Institutes of Health · 75N91022F00001 | $19,130,043 | Sep 15, 2027in 9 months | MD |
| Emerging Infectious Diseases Research Prevail I, III, V and Prevac MaliNational Institutes of Health · 75N91022F00018 | $4,008,921 | Sep 15, 2027in 9 months | MD |
| Manufacturing Process Development for Microbial Expression of GriffithsinNational Institutes of Health · 75N91021F00009 | $2,123,721 | Sep 16, 2027in 9 months | MD |
| FY25 Facilities Task Order a - Replace Wood Street Steam & Condensate PipingNational Institutes of Health · 75N91025F00004 | $3,035,294 | Sep 17, 2027in 10 months | MD |
| Nci-Arcdctd-26-0055 - Cptac Biospecimen Acquisition, Processing, and DistributionNational Institutes of Health · 75N91026F00020 | $4,538,288 | Sep 20, 2027in 10 months | MD |
| Hcmi/Cmdc Sequencing and Hcmi Searchable Catalog (Moonshot)National Institutes of Health · HHSN26100040 | $8,189,724 | Sep 24, 2027in 10 months | MD |
| Medicinal Chemistry Support to Ncats App Medchem InitiativeNational Institutes of Health · 75N91022F00025 | $6,260,028 | Sep 27, 2027in 10 months | MD |
| Ffrdc Moonshot Portfolio Task OrderNational Institutes of Health · 75N91019F00134 | $33,139,792 | Sep 30, 2027in 10 months | MD |
| FY25 to-BNational Institutes of Health · 75N91025F00007 | $2,034,923 | Sep 30, 2027in 10 months | MD |
| 126826 - B1040 Upgrade Chiller #2National Institutes of Health · 75N91026F00007 | $478,339 | Oct 7, 2027in 10 months | MD |
| FY25 Facilities to G Construction of Bmp Structures for Mde Storm-Water ComplianceNational Institutes of Health · 75N91025F00011 | $2,754,426 | Oct 27, 2027in 11 months | MD |
| 126827 Building 1023 Rooms 8 and 9 Bsc ReplacementNational Institutes of Health · 75N91026F00018 | $652,353 | Nov 15, 2027in 11 months | MD |
| FY20 Consolidated Facilities Task Order DNational Institutes of Health · 75N91020F00013 | $19,152,283 | Dec 2, 2027in 12 months | MD |
| Core Support for the Immune Cell NetworkNational Institutes of Health · 75N91021F00015 | $26,946,544 | Dec 31, 2027in 13 months | MD |
| Arpa-H Biomedical Data Fabric Toolbox ProgramNational Institutes of Health · 75N91024F00030 | $11,920,234 | Dec 31, 2027in 13 months | MD |
| FY26 126776 - B567 Replace Tunnel WasherNational Institutes of Health · 75N91026F00005 | $901,222 | Dec 31, 2027in 13 months | MD |
| FY26 to 10 - B539 Chilled Water Pumps Backup PowerNational Institutes of Health · 75N91026F00010 | $601,085 | Jan 13, 2028in 13 months | MD |
| FY26 126212 - Campus Compressed Gas SecurityNational Institutes of Health · 75N91026F00008 | $1,446,242 | Jan 19, 2028in 14 months | MD |
| FY26 126746 - B560 Emergency GeneratorNational Institutes of Health · 75N91026F00004 | $868,976 | Feb 7, 2028in 14 months | MD |
| Enabling Nci Clinical & Research Data SharingNational Institutes of Health · 75N91021F00013 | $98,565,259 | Feb 28, 2028in 15 months | MD |
| Ipp Nci Federally Funded Research and Development Center (Ffrdc) Contract to-FNational Institutes of Health · 75N91025F00010 | $2,532,970 | Feb 29, 2028in 15 months | MD |
| FY25 Task Order D - Base: Wo 126680 B539 East Basement Switchboard Replacement. Option 1: 126680A B539 West Attic Switchboard ReplacementNational Institutes of Health · 75N91025F00006 | $1,980,867 | Mar 3, 2028in 15 months | MD |
| Research, Development, and Production to Support Clinical Trials for Hiv Vaccines.National Institutes of Health · 75N91022F00006 | $14,347,608 | May 3, 2028in 17 months | MD |
| 126889 B571 Replace Chiller #3National Institutes of Health · 75N91026F00021 | $1,291,828 | May 3, 2028in 17 months | MD |
| 126869 B539 & 560 - Roof ReplacementsNational Institutes of Health · 75N91026F00030 | $1,511,990 | May 5, 2028in 17 months | MD |
| Pre-Clinical Assessment of Monoclonal Antibodies and Other Promising Vaccines/AgentsNational Institutes of Health · 75N91019F00135 | $16,481,250 | May 22, 2028in 18 months | MD |
| FY25 Facilities to E - 126663 B539 Misc Safety UpgradesNational Institutes of Health · 75N91025F00009 | $1,676,963 | Jun 30, 2028in 19 months | MD |
| FY26 125346 - B539 Storm Drain ReplacementNational Institutes of Health · 75N91026F00011 | $1,064,983 | Jun 30, 2028in 19 months | MD |
| Vrc Rapid Manufacturing Response: Nci Federally Funded Research and Development Center (Ffrdc) ContractNational Institutes of Health · 75N91022F00002 | $20,909,200 | Jul 2, 2028in 19 months | MD |
| On Behalf of Niaid-Dcr, Facilitate the Conduct of Two, Randomized Trials As Detailed Below in I and II: I. a Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational…National Institutes of Health · 75N91020F00009 | $89,563,956 | Jul 31, 2028in 20 months | MD |
| 126864 Multi Building Dry Chem Fire Suppression SystemNational Institutes of Health · 75N91026F00025 | $880,989 | Aug 21, 2028in 21 months | MD |
| 126297 Campus Evaluate & Replace Deficient Alternating Tread and Ship StairsNational Institutes of Health · 75N91026F00031 | $806,968 | Aug 23, 2028in 21 months | MD |
| N/aNational Institutes of Health · 75N91020F00029 | $25,726,378 | Sep 12, 2028in 21 months | MD |
| Characterization of Nanoparticles Encapsulating Oligonucleotides for Targeting Endocytosis in Nociceptors for the Treatment of Neuropathic PainNational Institutes of Health · 75N91023F00023 | $2,386,382 | Sep 14, 2028in 21 months | MD |
| Manufacturing of Tpm Suitable for Human UseNational Institutes of Health · 75N91023F00022 | $1,546,809 | Sep 14, 2028in 21 months | MD |
| Ebola Virus and Other Infectious DiseasesNational Institutes of Health · 75N91018F00059 | $56,381,886 | Sep 21, 2028in 22 months | MD |
| Characterizing the Mechanism of Action (Moa) of Investigational/Approved Cancer AgentsNational Institutes of Health · 75N91023F00019 | $4,568,362 | Sep 21, 2028in 22 months | MD |
| Development of an Integrated Canine Data Commons (Icdc)National Institutes of Health · 75N91018F00076 | $9,811,851 | Sep 23, 2028in 22 months | MD |
| Dcr Is Requesting the Services of Leidos Biomedical Research, Inc. to Initiate Management, Oversight, Execution, Closeout and Publication of Findings of a Prospective Observational Study of Adult…National Institutes of Health · 75N91020F00025 | $97,534,556 | Sep 24, 2028in 22 months | MD |
| This Task Order Is for the Proteomic Characterization Laboratory.National Institutes of Health · 75N91021F00010 | $17,159,340 | Sep 24, 2028in 22 months | MD |
| Cancer Models From Pediatric Brain and Solid Cancers (Cmdc)National Institutes of Health · 75N91020F00035 | $3,593,507 | Sep 24, 2028in 22 months | MD |
| 126729 Room 524 D, E, FNational Institutes of Health · 75N91026F00017 | $1,102,374 | Oct 19, 2028in 23 months | MD |
| 126797 Campus Replace BscsNational Institutes of Health · 75N91026F00028 | $1,912,753 | Oct 25, 2028in 23 months | MD |
| FY26 126771 - B1022 Autoclave ReplacementNational Institutes of Health · 75N91026F00009 | $1,747,456 | Nov 2, 2028in 23 months | MD |
| FY26 126816_B539 _B536 W End Fire AlarmNational Institutes of Health · 75N91026F00006 | $1,756,369 | Dec 18, 2028in 25 months | MD |
| Producing Usher III Retinal Organoids From Patient Cells to Measure the Effect of Drug CandidateNational Institutes of Health · 75N91025F00020 | $1,081,521 | Mar 15, 2029in 27 months | MD |
| Niaid Research Data Ecosystem Framework (Nidef)National Institutes of Health · 75N91020F00022 | $19,667,214 | May 30, 2029in 30 months | MD |
| The Objective of This Task Order Supports Niaids Goal to Conduct a Series of Standardized Phase 1 and Phase 2 Trials on Next-Generation Vaccines to Generate Data to Inform Decisions on Which…National Institutes of Health · 75N91023F00008 | $173,281,267 | May 31, 2029in 30 months | MD |
| Elaboration and Use of Syngenic Pre-Clinical Models for Cancer Drug DevelopmentNational Institutes of Health · 75N91021F00017 | $21,659,702 | Aug 21, 2029in 33 months | MD |
| Cell-Based Immunotherapy ProductsNational Institutes of Health · 75N91018F00077 | $53,523,069 | Aug 29, 2029in 33 months | MD |
| HHSN261201500003I; HHSN26100071; 400.021.0071.0001; Nci Cbiit; Appropriated; Expand Data Commons; 09/14/18-09/13/23National Institutes of Health · 75N91018F00071 | $72,263,032 | Aug 31, 2029in 33 months | MD |
| Proteomic and Antibody Production and CharacterizationNational Institutes of Health · 75N91024F00029 | $10,477,563 | Aug 31, 2029in 33 months | MD |
| Niaid Dcr Ocs-Irf, Irf Airs Translation of 89ZR-Df-IbalizumabNational Institutes of Health · 75N91022F00012 | $3,707,733 | Sep 16, 2029in 33 months | MD |
| Predictive Drug Testing in Organoid ModelsNational Institutes of Health · 75N91020F00032 | $11,113,648 | Sep 18, 2029in 34 months | MD |
| Integrated Dmpk and Toxicology Profiling of Ncats/Tdb Medicinal Chemistry Lead CandidatesNational Institutes of Health · 75N91026F00027 | $1,088,780 | Sep 20, 2029in 34 months | MD |
| PALM004: an Observational Study of the Natural History of Bundibugyo Virus DiseaseNational Institutes of Health · 75N91026F00033 | $11,725,031 | Sep 24, 2029in 34 months | MD |
| Md NetNational Institutes of Health · 75N91019F00139 | $181,379,395 | Oct 31, 2029in 35 months | MD |
| Niaid-Vrc-Mrna Vaccine Capability EstablishmentNational Institutes of Health · 75N91022F00013 | $25,098,522 | Jun 17, 2030in 43 months | MD |
| The Objective of This Task Order Supports Niaids Pandemic Response Repository Through Microbial and Immunologic Surveillance and Epidemiology (Premise)National Institutes of Health · 75N91023F00016 | $6,442,372 | Jul 14, 2030in 43 months | MD |
| Niaid Vrc - Premise - Pandemic Response Repository Through Microbial and Immunologic Surveillance and EpidemiologyNational Institutes of Health · 75N91022F00005 | $11,527,609 | Jul 30, 2030in 44 months | MD |
| Childhood Cancer Data Initiative: Clinical Trial Specimen Molecular Characterization (Ctsmc) ProgramNational Institutes of Health · 75N91020F00021 | $45,855,926 | Aug 31, 2030in 45 months | MD |
| Coordinated Facilities Requirements for FY25 - Facilities to INational Institutes of Health · 75N91025F00015 | $15,054,787 | Sep 13, 2030in 45 months | MD |
| Develop, Qualify Immunological Assays, and Provide Clinical Sample Testing for Aav-Based Gene Therapy Clinical CandidatesNational Institutes of Health · 75N91025F00024 | $4,557,516 | Sep 14, 2030in 45 months | MD |
| Manufacturing Process Development of 4-HbNational Institutes of Health · 75N91025F00018 | $1,270,276 | Sep 14, 2030in 45 months | MD |
| Manufacturing Cgmp Grade HydroxycobalamineNational Institutes of Health · 75N91025F00021 | $730,402 | Sep 14, 2030in 45 months | MD |
| Ffrdc Pth-1A Drug Product for Pediatric DosingNational Institutes of Health · 75N91026F00022 | $559,073 | Sep 20, 2030in 46 months | MD |
| The Niaid Mission and Scope Including Research and Development of Vaccines and Therapeutics for the Prevention and Treatment of Diseases of Human Concern, Including Malaria. the Vaccine Research…National Institutes of Health · 75N91023F00017 | $5,872,547 | Sep 23, 2030in 46 months | MD |
| Advance Universal Influenza Vaccine - Flu Mosaic Version 2 (FLUMOSV2)National Institutes of Health · 75N91021F00004 | $141,656,003 | Jan 28, 2031in 50 months | MD |
| Cmc Support for Ncats Rare Disease Platform Gene Therapy Trial ProjectsNational Institutes of Health · 75N91019F00138 | $28,263,054 | Mar 31, 2031in 52 months | MD |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount, $M | Share |
|---|---|---|
| National Institutes of Health195 contracts | 11,890 |
What they sell
| Industry | Amount, $M | Share |
|---|---|---|
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 · 168 contracts | 6,674 | |
| Facilities Support ServicesNAICS 561210 · 27 contracts | 5,217 |
Where the work is
| Place of work | Amount, $M | Share |
|---|---|---|
| Maryland195 contracts | 11,890 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at National Institutes of Health: see the list.
Get new notices like Leidos Biomedical Research's work
New contract opportunities under NAICS 541715, research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy